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Some challenges in bacterial infectious diseases
We are aware of the enormous burden of infectious diseases in 
sub-Saharan Africa. The onslaught of HIV and its accompanying 
infections such as tuberculosis poses an all-encompassing burden 
on our health care system and a challenge to our resources and 
resourcefulness.
Infection occurs when pathogens overwhelm the immune response 
of the host. This happens when a particularly virulent pathogen is 
encountered, or when a large number of organisms are introduced 
into a site or overgrow as a result of disturbance of normal flora. The 
outcome is determined by the ability of the local and/or systemic 
immune defences of the host to deal with such an onslaught. 
The balance between pathogens and hosts is therefore ever changing, 
driven by the evolution of both pathogen and host characteristics.
Social events like population movement and the hosting of major 
sporting events enhance the complexity of the epidemiology of 
transmissible infections, while advances in diagnostic techniques 
and management modalities continuously change our ability to 
combat disease. 
This cumulates in the growth of new and essential knowledge that 
needs to be constantly assimilated by the practitioner so that he or 
she is able to deal effectively with a broad spectrum of infectious 
diseases.
Apart from problems associated with the management of individual 
patients, other issues concerning infectious diseases need to be 
addressed on a national scale by constant vigilance and focused 
research. We have to be alert and able to identify outbreaks of not 
only new pathogens, but also altered pathogen characteristics, for 
example the emergence and spread of multi-resistant tuberculosis 
in our communities and hyper-virulent and highly transmissible 
outbreaks of community-acquired Staphylococcus aureus that are 
currently occurring in many parts of the world. We need to strengthen 
infection control in hospitals and in the community, and to enhance 
our now well-established networks of pathogen surveillance that are 
providing essential information on the ever-changing landscape of 
infectious diseases in our communities (see the GERMS-SA website 
at http://www.nicd.ac.za/units/germs/germs.htm).
There are enough problems in the field of infectious diseases to fill 
several issues of this journal, but in this issue we bring together the 
expertise of leading local medical microbiologists and clinicians 
working in the field of infectious diseases to inform some of the day-
to-day dilemmas practitioners have to deal with when diagnosing 
and managing infection.
Slightly more than a decade ago, vaccination against invasive 
Haemophilus influenzae disease was rolled out in children. Last 
year, a vaccine against the more dominant serotypes of Streptococcus 
pneumonia was also introduced into the South African vaccination 
schedule. Nevertheless, bacterial meningitis remains a dominant 
cause of child mortality and the impact of these vaccines needs to 
be carefully monitored in our population. Dr Anne von Gottberg of 
the National Institute for Communicable Diseases updates us on the 
vaccines and their current and future impact on infection with the 
capsulated pathogens.
In the light of the mobility of our population and the tourist boom 
surrounding the 2010 FIFA World Cup, Professor Marc Mendelson 
and his colleagues working at the Division of Infectious Diseases 
and HIV Medicine at Groote Schuur Hospital highlight some of the 
more common and serious diseases we may encounter in travellers. 
Significant advancement towards the early diagnosis of tuberculosis 
has been made, and more rapid testing is now being rolled out by the 
National Health Laboratory Services as well as laboratories servicing 
the private sector.  Marc Nicol, Professor of Medical Microbiology at 
the University of Cape Town, has been involved with the development 
and evaluation of many of these initiatives.  He provides guidelines 
on the application and limitations of these tests, and gives us a 
glimpse of what can be expected in the near future.
Soft-tissue infections remain one of the most common and often 
difficult to treat infections encountered by the general practitioner. 
Professor Jan Pretorius, from the Department of Surgery at the 
University of Pretoria, gives a clear perspective on the different 
forms of complicated and serious soft-tissue infections. He explains 
the underlying pathogenesis of each form, and provides us with 
sound guidelines to diagnosis and effective management.
Dr Jantjie Taljaard of the Centre for Infectious Diseases at the 
Stellenbosch Faculty of Health Sciences provides an overview of the 
risk factors, management and complications of infections resulting 
in sepsis.
Finally, Dr Marthinus Senekal of Pathcare Laboratories provides ‘in 
a nutshell’ guidelines to use and interpret antimicrobial sensitivity 
testing and to direct duration of therapy.
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